4. Nov 2026 | B2B_Patient-Reported Outcome., B2B_RWD
The days of tracking visitors on public patient websites are over. For digital patient engagement projects, it is no longer enough to simply document visits, reach or downloads. What is of particular interest to pharmaceutical companies is how specific patient groups...
7. Oct 2026 | B2B_Patient_Engagement
When people talk about longevity, the focus is often on new active substances, biomarkers, prevention programs or technological innovations. For many people, however, a long life in good health depends on a less spectacular factor: their daily management of health...
1. Jul 2026 | B2B, B2B_Patient_Engagement
How can pharmaceutical companies reach patients directly without taking regulatory risks or losing relevance? This question shapes the current discussion around direct-to-patient approaches. While direct patient communication has been established in the USA for...
3. Jun 2026 | B2B_Patient_Engagement
Cardiovascular guidelines are considered the gold standard of evidence-based medicine. The recommendations of the European Society of Cardiology and the European Atherosclerosis Society for lowering LDL cholesterol are clear, differentiated by risk profiles, and...